A significant upregulation of JAG1 (p < 0.0001), PTGS2 (p < 0.0001) and GUCY2C (p = 0.0349) genes was observed in blood cells from CRC patients compared to controls (Figure 1A–C). This evidence concerns the gene PTGS2 and colorectal carcinoma.